| | N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine| 基本信息 更多信息 |
| 中文名称: | | | 中文同义词: | | | 英文名称: | N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine | | 英文同义词: | N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine;Nikkomycin QZ;(2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid;L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI) | | CAS号: | 95259-50-0 | | 分子式: | C24H32N6O12 | | 分子量: | 596.54 | | EINECS号: | | ![N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine|](/CAS/20210305/GIF/95259-50-0.gif) |
|
| 按国家浏览N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine国外供应商 |
中国供应商 |
|
N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|